用追踪报告评估类固醇诱导的骨质疏松症预防在医院和社区药剂师之间的合作中
Nonoko Ishihara1, Shuji Yamashita2, Shizuno Seiki2
1Laboratory of Home Team Care Pharmacy, Gifu Pharmaceutical University, 1-25-4 Daigaku Nishi, Gifu 501-1196, Gifu, Japan.
Pharmacy (Basel, Switzerland)
|May 28, 2024
概括
社区药剂师通过向医生推治疗方法,改善了葡萄糖皮质激素诱导的骨质疏松症 (GIOP) 的预防. 这项干预成功地弥合了葡萄糖皮质醇 (GC) 治疗患者的指导方针和临床实践之间的差距.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 葡萄糖皮质醇诱导的骨质疏松症 (GIOP) 是葡萄糖皮质醇 (GC) 治疗的常见副作用.
- 既定的GIOP预防指南与其在临床实践中的实施之间存在很大的差距.
- 解决这一证据与实践差距对于患者安全和GC治疗的有效管理至关重要.
研究的目的:
- 评估医院-社区药剂师协作干预措施在改善GIOP预防准则遵守方面的有效性.
- 评估药剂师在向医生推骨质疏松症治疗时使用的追踪报告 (TR) 的影响.
主要方法:
- 实施了一项涉及医院和社区药剂师的合作干预.
- 药剂师通过追踪报告 (TRs) 确定了没有接受骨质疏松症治疗的GIOP (骨折风险评分≥3) 风险患者.
- 向处方医生提出了骨质疏松症治疗的建议,使用从电子病历中收集的数据.
主要成果:
- 在391名被评估的患者中,有45人有资格接受TR,其中34人 (75.6%) 是男性.
- 普雷尼索隆是最常被处方的GC,泌尿器科是主要的治疗部门.
- 在45名符合条件的患者中,有19名 (42.2%) 通过TRs接受了药剂师的建议,这使得指南遵守率从87%增加到92.5%.
结论:
- 协作干预有效地弥合了接受GC治疗的患者在GIOP预防方面的证据与实践差距.
- 追踪报告 (TRs) 是改善准则遵守和防止GIOP的宝贵工具.
- 扩大这个由药剂师领导的倡议是有必要的,以进一步加强GIOP的预防策略.
相关概念视频
Pharmacovigilance
825
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
825
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K


